Carbamazepine but not pregabalin impairs eye control: A study on acute objective CNS side effects in healthy volunteers

Epilepsy Research

Volumn 88, Issue 2-3, 2010, Pages 145-150

  Rémi, Jan ^a   Hüttenbrenner, Angelika ^a   Feddersen, Berend ^a   Noachtar, Soheyl ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antiepileptic drug; CNS side effects; Electrooculography; Posturography

Indexed keywords

CARBAMAZEPINE; PREGABALIN;

ADULT; ARTICLE; BODY EQUILIBRIUM; BODY POSTURE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INDUCED HEADACHE; ELECTROOCULOGRAPHY; EYE MOVEMENT CONTROL; EYE MOVEMENT DISORDER; FEMALE; GAIT DISORDER; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SACCADIC EYE MOVEMENT; SIDE EFFECT; SINGLE DRUG DOSE; SLOW DRUG RELEASE; STABILOGRAPHY;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROOCULOGRAPHY; EYE MOVEMENTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; POSTURE; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 75849118657     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.10.007     Document Type: Article

References (34)

1. Anonymous. Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Collaborative Group for Epidemiology of Epilepsy. Epilepsia 27 (1986) 323-330
2. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., and Messmer S. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
3. Bittencourt P.R., Gresty M.A., and Richens A. Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects. J. Neurol. Neurosurg. Psychiatry 43 (1980) 1119-1124
4. Bittencourt P.R., Wade P., Smith A.T., and Richens A. The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentrations. Br. J. Clin. Pharm. 12 (1981) 523-533
5. Brandt C., May T., Pohlmann-Eden B., Nieder E., Elsner H., Witte-Boelt K., Schuermann I., and Ebner A. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients. Seizure (2009)
6. Brandt T. Vertigo: Its Multisensory Syndromes (1991), Springer, London
7. Brodie M.J., Perucca E., Ryvlin P., Ben-Menachem E., and Meencke H.J. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68 (2007) 402-408
8. Brodie M.J., Richens A., and Yuen A.W. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345 (1995) 476-479
9. Buttner U., and Grundei T. Gaze-evoked nystagmus and smooth pursuit deficits: their relationship studied in 52 patients. J. Neurol. 242 (1995) 384-389
10. Cohen A.F., Ashby L., Crowly D., Land G., Peck A.W., and Miller A.A. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br. J. Clin. Pharm. 20 (1985) 619-629
11. Dieterich M., Straube A., Brandt T., Paulus W., and Buttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J. Neurol. Neurosurg. Psychiatry 54 (1991) 627-632
12. Ditterich, J., 1995. Untersuchung in die Sakkadensteuerung involvierter Gehirnstrukturen mittles Computertools. Thesis. Technical University of Munich, Munich.
13. Dybdal D., and Gale K. Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus. J. Neurosci. 20 (2000) 6728-6733
14. Errante L.D., and Petroff O.A. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 12 (2003) 300-306
15. Field M.J., Cox P.J., Stott E., Melrose H., Offord J., Su T.Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R.A., Hendrich J., Dolphin A.C., Webb T., and Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 17537-17542
16. Hamandi K., and Sander J.W. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 12 (2006) 73-78
17. Hamilton M.J., Cohen A.F., Zuen A.W.C., Harkin N., Land G., Weatherley B.C., and Peck A.W. Carbamazepine and lamotrigine in healthy volunteers: relevance of early tolerance and clinical trial dosage. Epilepsia 34 (1993) 166-173
18. Kim K.H., Ha J.H., Chung S.H., Kim C.T., Kim S.K., Hyun B.H., Sawada K., Fukui Y., Park I.K., Lee G.J., Kim B.K., Lee N.S., and Jeong Y.G. Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice. J. Vet. Sci. 4 (2003) 209-212
19. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 342 (2000) 314-319
20. Leigh R.J., and Zee D. The Neurology of Eye Movement (1991), Davis, Philadelphia
21. Leisman G., and Schwartz J. Ocular-motor function and information processing: implications for the reading process. Int. J. Neurosci. 8 (1977) 7-15
22. Levy R.H., Pitlick W.H., Troupin A.S., Green J.R., and Neal J.M. Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther. 17 (1975) 657-668
23. May T.W., Rambeck B., Neb R., and Jurgens U. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. Ther. Drug. Monit. 29 (2007) 789-794
24. Messenheimer J., Ramsay R.E., Willmore L.J., Leroy R.F., Zielinski J.J., Mattson R., Pellock J.M., Valakas A.M., Womble G., and Risner M. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 35 (1994) 113-121
25. Noachtar S., von Maydell B., Fuhry L., and Buttner U. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers. Epilepsy Res. 31 (1998) 47-57
26. Pande A.C., Crockatt J.G., Feltner D.E., Janney C.A., Smith W.T., Weisler R., Londborg P.D., Bielski R.J., Zimbroff D.L., Davidson J.R.T., and Liu-Dumaw M. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am. J. Psychiatry 160 (2003) 533-540
27. Paulus W.M., Straube A., and Brandt T. Visual stabilization of posture. Physiological stimulus characteristics and clinical aspects. Brain 107 (1984) 1143-1163
28. Remler B.F., Leigh R.J., Osorio I., and Tomsak R.L. The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy. Neurology 40 (1990) 791-796
29. Salinsky M., Oken B., and Binder L. Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia 37 (1996) 181-187
30. Takeuchi Y., Takasu K., Ono H., and Tanabe M. Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. Neuropharmacology 53 (2007) 842-853
31. Tedeschi G., Casucci G., Allocca S., Riva R., Di Costanzo A., Tata M.R., Quattrone A., Baruzzi A., and Bonavita V. Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis. Epilepsia 30 (1989) 62-66
32. Umeda Y., and Sakata E. Equilibrium disorder in carbamazepine toxicity. Ann. Otol. Rhinol. Laryngol. 86 (1977) 318-322
33. Vranken J.H., Dijkgraaf M.G., Kruis M.R., van der Vegt M.H., Hollmann M.W., and Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 136 (2008) 150-157
34. Wheeler S.D., Ramsay R.E., and Weiss J. Drug-induced downbeat nystagmus. Ann. Neurol. 12 (1982) 227-228